Could this Healthcare Stock really climb 227.06% in 2023?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [How to invest in AI's Fast-Growing Market]( [Find Out How Investors Can Benefit in the AI Technology Race]( --------------------------------------------------------------- August 16, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [ChatGPT Is Already "Old School"]( good as ChatGPT is at writing content, it still doesn't understand what it's saying. But a new AI technology breakthrough will understand and process information like a human. One young company is leading the way. [See How This AI Innovation Could Impact Investors Like You]( --------------------------------------------------------------- [NICE]( Symbol: [NICE]( Recent Price: $214.76 Average Analyst Price Target: $260.00 (29.68%) Market Cap: $13.80B Last Year's EPS: $2.04 Consensus EPS Forecast: $1.98 Expected Earnings Date: Aug 17 2023 Recent Analyst Action: Tyler Radke, analyst at Citi, reiterates coverage on [NICE (NICE)]( in the Technology sector with a Buy rating and a price target of $338 (1 day ago). [TipRanks.com]( also reports that [NICE]( currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $260.00 . The target pricing ranges from a high forecast of $260.00 down to a low forecast of $260.00. [NICE (NICE)](’s last closing price was $214.76 which would put the average price target at 29.68% upside. Here are 3rd party ratings for [NICE](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 36% (90 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [5G Stock CRUSHES Earnings!!]( Street is loading up on shares of one 5G SuperStock (with more than $2 billion invested!). Why? Because the stock brings in more cash than IBM, Facebook and even Google! Yet it trades for just $3. [Get the scoop on the 5G SuperStock right here.]( --------------------------------------------------------------- [Walmart]( Symbol: [WMT]( Recent Price: $159.18 Average Analyst Price Target: $164.88 (9.35%) Market Cap: $430.85B Last Year's EPS: $1.71 Consensus EPS Forecast: $1.32 Expected Earnings Date: Aug 17 2023 Recent Analyst Action: Mark Astrachan, analyst at Stifel Nicolaus, reiterates coverage on [Walmart (WMT)]( in the Consumer Defensive sector with a Hold rating and a price target of $167 (1 day ago). [TipRanks.com]( also reports that [Walmart]( currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $164.88 . The target pricing ranges from a high forecast of $190.00 down to a low forecast of $136.00. [Walmart (WMT)](’s last closing price was $159.18 which would put the average price target at 9.35% upside. Here are 3rd party ratings for [WMT](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 17% (43 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Farfetch]( Symbol: [FTCH]( Recent Price: $4.87 Average Analyst Price Target: $32.73 (96.51%) Market Cap: $2.08B Last Year's EPS: -$0.25 Consensus EPS Forecast: -$0.27 Expected Earnings Date: Aug 17 2023 Recent Analyst Action: Edward Yruma, analyst at Piper Sandler, reiterates coverage on [Farfetch (FTCH)]( in the Technology sector with a Hold rating and a price target of $6 (1 month ago). [TipRanks.com]( also reports that [Farfetch]( currently has 13 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $32.73 . The target pricing ranges from a high forecast of $75.00 down to a low forecast of $5.00. [Farfetch (FTCH)](’s last closing price was $4.87 which would put the average price target at 96.51% upside. Here are 3rd party ratings for [FTCH](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 27% (67 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI to Disrupt Energy Market (Huge Potential Gains!)]( orb represents the largest untapped energy source in the world… And although this energy resource is unknown by 99% of the public… It makes gas, coal, oil, wind, hydropower, solar, fusion… It makes them all look like small fries… In fact, just one year of this untapped resource in the USA alone provides 5X as much power as the largest oil field on Earth… And this resource is about to be unleashed on the world like never before with the help of one tiny Silicon Valley company…[Click here for all the details…]( --------------------------------------------------------------- [Nano-X Imaging]( Symbol: [NNOX]( Recent Price: $9.41 Average Analyst Price Target: $30.00 (218.81%) Market Cap: $555.74M Last Year's EPS: -$0.86 Consensus EPS Forecast: -$0.34 Expected Earnings Date: Aug 17 2023 Recent Analyst Action: Ross Osborn, analyst at Cantor Fitzgerald, reiterates coverage on [Nano-X Imaging (NNOX)]( in the Healthcare sector with a Buy rating and a price target of $30 (2 months ago). [TipRanks.com]( also reports that [Nano-X Imaging]( currently has analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $30.00 . The target pricing ranges from a high forecast of $30.00 down to a low forecast of $30.00. [Nano-X Imaging (NNOX)](’s last closing price was $9.41 which would put the average price target at 218.81% upside. Here are 3rd party ratings for [NNOX](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 39% (153 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Calliditas Therapeutics]( Symbol: [CALT]( Recent Price: $19.33 Average Analyst Price Target: $45.25 (134.09%) Market Cap: $531.32M Last Year's EPS: -$0.67 Consensus EPS Forecast: -$0.38 Expected Earnings Date: Aug 17 2023 Recent Analyst Action: Arthur He, analyst at H.C. Wainwright, reiterates coverage on [Calliditas Therapeutics (CALT)]( in the Healthcare sector with a Buy rating and a price target of $60 (1 month ago). [TipRanks.com]( also reports that [Calliditas Therapeutics]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $45.25. The target pricing ranges from a high forecast of $74.00 down to a low forecast of $15.27. [Calliditas Therapeutics (CALT)](’s last closing price was $19.33 which would put the average price target at 134.09% upside. Here are 3rd party ratings for [CALT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 32% (80 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Tiny Gem in $59Bn Market]( Equity Analyst says this one stock could climb over 1,823% within the next year. [Get Symbol]( --------------------------------------------------------------- [LumiraDx]( Symbol: [LMDX]( Recent Price: $0.43 Average Analyst Price Target: $1.39 (227.06%) Market Cap: $159.37M Last Year's EPS: -$0.32 Consensus EPS Forecast: -$0.15 Expected Earnings Date: Aug 17 2023 Recent Analyst Action: Vijay Kumar, analyst at Evercore ISI, reiterates coverage on [LumiraDx (LMDX)]( in the Healthcare sector with a Buy rating and a price target of $1 (2 months ago). [TipRanks.com]( also reports that [LumiraDx]( currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $1.39. The target pricing ranges from a high forecast of $2.70 down to a low forecast of $0.75. [LumiraDx (LMDX)](’s last closing price was $0.43 which would put the average price target at 227.06% upside. Here are 3rd party ratings for [LMDX](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Bottom 39% (153 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- [Globant SA]( Symbol: [GLOB]( Recent Price: $171.11 Average Analyst Price Target: $205.33 (27.99%) Market Cap: $7.43B Last Year's EPS: $1.4 Consensus EPS Forecast: $1.27 Expected Earnings Date: Aug 17 2023 Recent Analyst Action: Arturo Langa, analyst at Itau Unibanco, reiterates coverage on [Globant SA (GLOB)]( in the Technology sector with a Buy rating and a price target of $230 (6 days ago). [TipRanks.com]( also reports that [Globant SA]( currently has 20 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $205.33 . The target pricing ranges from a high forecast of $207.00 down to a low forecast of $204.00. [Globant SA (GLOB)](’s last closing price was $171.11 which would put the average price target at 27.99% upside. Here are 3rd party ratings for [GLOB](: - TipRanks.com: Strong Buy - TradingView.com: Strong Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Top 42% (106 out of 252) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [AI Getting Close to Thinking Like Humans]( experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do. [See the Young Company Behind This Revolutionary Advancement]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. [If you are not a human, click here.]( MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software